Can We Predict Prostate Cancer Metastasis Based on Biomarkers? Where Are We Now?

The incidence of prostate cancer (PC) has risen annually. PC mortality is explained by the metastatic disease (mPC). There is an intermediate scenario in which patients have non-mPC but have initiated a metastatic cascade through epithelial–mesenchymal transition. There is indeed a need for more and...

Descripción completa

Detalles Bibliográficos
Autores principales: San Francisco, Ignacio F., Rojas, Pablo A., Bravo, Juan C., Díaz, Jorge, Ebel, Luis, Urrutia, Sebastián, Prieto, Benjamín, Cerda-Infante, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420177/
https://www.ncbi.nlm.nih.gov/pubmed/37569883
http://dx.doi.org/10.3390/ijms241512508

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10420177/
https://www.ncbi.nlm.nih.gov/pubmed/37569883
http://dx.doi.org/10.3390/ijms241512508

Ejemplares similares